صفحه 1:
صفحه 2:
Overview ماوت 1۳ از ۲و ond strotesies
Por uoeess to wedivices iat (Priva?
Ouse studes Exppt, Oqoada ood Gout @Prica
1600 tic Egyptian priest-doctors
al dveases Egyptian pharmacists dispensed
al deus, Ineloding ops.
صفحه 3:
2/۳۳
1۳0۲ صصه ماه عه “ia it oP اس = ip jet u sell pat oP the puzzle thet i
kowperiay access to wedictes?
4. DRIPG-cexwplcct IP Law passed is CODE: WED Priewdy kw;
8. OG-P1O واه نویه Por a joey tere cow! IPRs issues
سوت
91۳68 tissues ore ot deat wiki Oru, but rae though uoder-he-table-
deds ondlor buck-door backwulog wikia he corporate sevir (Bx: Peg:
foterPerva dPa Ga (Dice Phaw);
۰ مه عمجم ی Por aqrer thot (PRs have oot oPPevted their
work! Duay dPRereut issues ure keeper 6060
“Lak oP vet ta the Dray auhomtes ool ta he loo peur C
متا سا مر( & week, Prennvented, covery ~30% of the portion
“Dp traxepared syste Por prick, oP ات
~Orry Ike Plekd research dove oc زارت oP (oP Pordabke) coehetces);
صفحه 4:
)/۷ ۵۳/۲۰ bessove مورا
ره مر Wage نا توت امه نا
بر مایت له ماه موه diseuse, whe it werits
hove u stribiogy bod sitratioc
Oiseuse-spechic advocacy works work beter thos yeceral
“oovess to wedicices” adver}
however, voly to woke the جر سس افیا سفق
but udless pou ore bebied poteats’ youps, روتوم wedi
the wise dors ut fost;
Oe tock exepiricd iePorewaticd oo ovalobiliy oP (cheaper!
thevreticdly oPPordable) wedicices;
Phe vy 9 IP R-relted cases brought bePore the Ovurt
hove bees wo by the yeverio wonwPacturers}
صفحه 5:
Oxunde und the COC Reqioa
16 لین( مب ore hPevied wits WOODS, O.S pervect oF
۳
Over OO OOO people (BO موم of those kt اه وه(
تمو یت امه رو
tice موی نا نطو ول( ان و عط()
۳ ۳ ihe debees, crore ond heat doeases;
Over 90% of dl pedoiae Reports ی ی و لو( و
Dhere oe? pharmaceuticals وله — butane ol yeceric
tack the Pores quatiy checizds-Orpka Pacton/} هلو
Oade a cowernnicaion to the WTO Orarrd Por DRAPE oa tts priory
تور او له بجاو errs Bor
صفحه 6:
تم(
hee 9 puted kv posed ۰ 1965 نا - سس ۳۵۲۵ بل ساسا
سس ۱ ۱۵۲۵۵
tr OSE terkedery PRIPO, مسب 0۵ تسب
] tee COOO t hoy beva havier nePore بيدا 103 لمهي خاب Wo beta ther kato
pepe with ۱۵۲۱۵ - سا ما Teketrd Property (il = Prot ready te parka د
5009 = w prowess tome!
بیان مه سره سا )سل he Ord
لاه سا مت نوی بت با 6006 سم
procevees Por ww wee; من من سس Oil -
wade; موی مه من جات اب(
= Dot clear va hehe caturdly occ urrieny suber bua be putt;
— Research exvepion ody provides Por exporter ver;
= Requires coweul Prow pout weer Por parched وميه
تفیل wee oP court to eet Ob hicks ty keorghs
صفحه 7:
عصاسضصه سست
+ Ord COO Reyerra Pokey send Protenl ox Dikrotoa oP Pubke Tealts Retated OPO-
DRAPE مر( سا نمی سای oP ساسا بو اما لت(
6000
(ue) 4 ينص حت سو لجس ) ۵00 سنسیال
ee ee ee
shure.
Robey: “reed cap” 8
Orel expkiwe pubk: heuiherekaeed DRIPC Phebe =
to ba ساسا ۱۵۲۵۵ oP ماوت با بت Pranks poly revounnesnbtioce -
Raber exe
MRP Plerdbis have ox مات ی تا لجی ماما 10 لح سم
1 = باه پم مس و
مایا ان wow سامت مت 000 با @rotentt prouske «nitkekes +
سم 060 لمن 16 سا ی - 56۵06 ۸ 1/۵/۵۹۵۵ ۵00 Phe Ord +
وسسسلجميه تحصن أن - BTL ی الم ۰
تصاهان
ماما مت نی ۵00 ٩
(سسبی رجهجمت مت لب 0100) نموت 10 ۵ مس لس
و
= Burwe of
صفحه 8:
Goutk @Prica
Gout @Prica kus suovessPuly used poxwpetiive how to
challeage the high post oP ROs oad uses lower vost
۱ وت versio.
- In 2003, TAC, S27 and partners challenged the high cost of AZT and NVP
sold by GSK and BI. (Submitted affidavits showing excessive pricing). CC
found that pricing was excessive and referred to tribunal at which point 3-4
generic companies were licensed to sell each medicine. The cost of a AZT,
3TC, NVP regimen dropped from over R5,000 (US$700) per month in late
90s to less than R50 (US$7) per month today.
After engaging with MSD (Merck) since 2002, TAC and S27 launched a
complaint with the CC in 2007, that MSD was unlawfully refusing to license
on lawful terms, which blocking entry of cheaper generics and FDCs. MSD
responded by licensing 4 companies and the complaint was dropped. The
price of EFV dropped from R166.90 per month to R40 today.
In 2008, TAC and S27 filed a complaint around the merger of Aspen and
GSK. The complaint identified that competition for ABC would be impacted
by the merger when the medicine came off patent. As a condition of the
merger GSK was required to grant at least 5 VLs to manufacture and sell
ABC. The price halved in the 2011- 2013 tender from the 2008 - 2010 price.
صفحه 9:
(۳ the Pilon of sirvag cases hos worked وه جوم مرخ و
را با his «vay ool be لصو 1١ وومشوصم oi bot oF rere ord
resources by te OBO oad cnet be coried out oa a creditor by
00 bee,
POC's cored casppuicne is ty aed the
utes Bot to Pulp utilize ol PRIPG
:ناملا
* مومس ران und procedure
© Groadards oF pateatabiliy
٠ Exaviciogy cod ppposiny poets